LumaCyte is an advanced research and bioanalytics instrumentation company that has a mission to provide researchers with a transformational diagnostic tool. This tool accelerates medical and pharmaceutical discoveries through novel cell analysis and sorting. LumaCyte's groundbreaking technology is based on Laser Force Cytology™ (LFC™), which measures optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell.

Their label-free platform technology has a wide range of applications, including viral infectivity for vaccine development, cell and gene therapy monitoring, cancer biology research, CAR T-cell immunotherapy, and pre-clinical drug discovery. The innovative technology empowers researchers to better understand disease, accelerate therapies, and advance cures. By eliminating the need for genetic labeling or antibody-based diagnostics, LumaCyte's platform enables a deeper understanding of cell-based biological systems.

With a commitment to innovation and discovery, LumaCyte is driving advanced analytics and accelerating medical and pharmaceutical breakthroughs